Phase 3 Glycemia Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
Vertex Pharmaceuticals Incorporated52 enrolled29 locationsNCT04786262
Recruiting
Phase 3
Canakinumab for the Treatment of Postprandial Hypoglycemia
Postprandial Hypoglycemia
University Hospital, Basel, Switzerland56 enrolled2 locationsNCT05401578
Completed
Phase 2Phase 3
To investigate the acute effects of different doses of chilli ingestion on blood glucose, insulin, blood vessel function and energy expenditure.
postprandial hyperglycemiapostprandial hyperinsuliemia
Dr. Kiran DK Ahuja20 enrolled1 locationACTRN12609000890235